Hydrogen and Plasma Boost Stem Cell Therapy for Healing
- Authors
- Mikhail Yu Artamonov, Felix A Pyatakovich, Inessa A Minenko
- Journal
- Antioxidants
- Year
- 2024
- DOI
- 10.3390/antiox13121584
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- United States
- Health Condition
- Wound Healing Disorders
- Body System
- Immune System
TL;DR
Scientists found that combining two special treatments—molecular hydrogen and cold plasma—together makes stem cell therapy work much better by protecting the cells from damage and helping them survive and heal tissues faster.
Key Finding
Molecular hydrogen and cold atmospheric plasma may work synergistically to reduce oxidative stress and improve mesenchymal stem cell survival and function in regenerative medicine applications.
Summary
This review examines how molecular hydrogen (H2) and cold atmospheric plasma (CAP) might work together to improve stem cell therapy. Mesenchymal stem cells are used in regenerative medicine to repair tissues, but their effectiveness is often limited by oxidative stress (cellular damage from unstable molecules) and other factors. The review suggests that H2 reduces harmful reactive oxygen species and activates protective cellular pathways, while CAP alters the cellular environment in ways that may help stem cells survive and function better. Together, these two approaches might enhance stem cell therapy for wound healing, nerve protection, and tissue damage from lack of blood flow.
Practical Takeaway
This is a review article summarizing existing research rather than a new experimental study, and it focuses on stem cell therapy rather than hydrogen water for general health. The evidence discussed is largely from laboratory and animal studies, not human trials. While the findings suggest potential therapeutic applications, much more research—including human clinical trials and long-term safety studies—is needed before these combined approaches could be used in clinical practice.
Abstract
In regenerative medicine, mesenchymal stem cells (MSCs) have shown their importance and potential in tissue reconstruction and immune system modification. However, such cells' potential is often diminished by factors such as oxidative stress, immune rejection, and inadequate engraftment. This review highlights the role of molecular hydrogen (H2) and cold atmospheric plasma (CAP) as adjunct therapies to improve the effectiveness of MSC therapy. H2 has strong antioxidative and anti-inflammatory actions as it quenches reactive oxygen species and positively stimulates the Nrf2 pathway that promotes MSC survival and life. CAP, being a modulated source of ROS and RNS, also assists MSCs by altering the cellular redox balance, thus facilitating cellular adaptation, migration, and differentiation. H2 and CAP in conjunction with each other assist in establishing an ambience favorable for promoting MSCs' survival and growth abilities, and reduce the healing time in various pathways such as wound, neuroprotection, and ischemia. Besides these concerns, this review also covers the best administration routes and doses of H2 and CAP together with MSCs in therapy. This study informs on a novel dual method aimed at improving the outcome of MSC therapy while adding several molecular targets and relevant clinical uses concerning these therapies. Research of the future has to deal with bettering these protocols so that the therapeutic benefits can be maximized without long-term implications for clinical applications.